LPAR3, which is overexpressed in ovarian tumours, promotes Gi/MAPKs/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κβ) signalling to drive tumour growth and metastasis [79]. This evidence concerns the gene LPAR3 and neoplasm.